Literature DB >> 30769123

W protein expression by Newcastle disease virus.

Julia Karsunke1, Sandra Heiden1, Magdalena Murr1, Axel Karger1, Kati Franzke2, Thomas C Mettenleiter1, Angela Römer-Oberdörfer3.   

Abstract

Differential editing of transcripts from the Newcastle disease virus (NDV) phosphoprotein gene results in mRNAs capable of encoding the phosphoprotein (P), the V protein, and the W protein which share a common N-terminus but specify different C-termini. Whereas the expression and viral incorporation of the P - and V proteins by NDV has been documented, evidence for the existence of a W protein was lacking. To analyze expression of the NDV W protein, two peptides encompassing predicted antigenic sites of the unique C-terminal W protein amino acid sequence of NDV Clone 30 were used for the generation of W-specific rabbit antisera. One of them detected plasmid-expressed W protein and identified W protein after infection by indirect immunofluorescence and Western blot analyses. W protein was absent in cells infected by a newly generated recombinant NDV lacking W protein expression. Furthermore, Western blot and mass spectrometric analyses indicated the incorporation of W protein into viral particles. Confocal microscopic analyses of infected cells revealed nuclear accumulation of W protein that could be attributed to a bipartite nuclear localization sequence (NLS) within its unique C-terminal part. Redistribution of the W protein to the cytoplasm within transfected cells confirmed functionality of the NLS after mutation of its two basic clusters. This finding was additionally corroborated in cells infected with a recombinant virus expressing the mutated W protein.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Newcastle disease virus; W protein

Mesh:

Substances:

Year:  2019        PMID: 30769123     DOI: 10.1016/j.virusres.2019.02.003

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  10 in total

1.  Mechanisms and consequences of Newcastle disease virus W protein subcellular localization in the nucleus or mitochondria.

Authors:  Yanling Yang; Jia Xue; Qingyuan Teng; Xiao Li; Yawen Bu; Guozhong Zhang
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

2.  Circulation of at Least Six Distinct Groups of Pigeon-Derived Newcastle Disease Virus in Iran Between 1996 and 2019.

Authors:  Aidin Molouki; Mohammad Soltani; Mohsen Mahmoudzadeh Akhijahani; Mohammad Hossein Fallah Merhabadi; Alireza Abtin; Abdelhamid Shoushtari; Arash Ghalyanchi Langeroudi; Swee Hua Erin Lim; Esmaeel Allahyari; Mohammad Abdoshah; Seyed Ali Pourbakhsh
Journal:  Curr Microbiol       Date:  2021-05-18       Impact factor: 2.188

3.  Root-preferential expression of Newcastle virus glycoproteins driven by NtREL1 promoter in tobacco hairy roots and evaluation of oral delivery in mice.

Authors:  Narges Arkian Boroujeni; Somayeh Behjat Khatouni; Mohammad Javad Motamedi; Shaghayegh Afraz; Mahyat Jafari; Ali-Hatef Salmanian
Journal:  Transgenic Res       Date:  2022-01-10       Impact factor: 2.788

4.  Cellular MicroRNA Expression Profile of Chicken Macrophages Infected with Newcastle Disease Virus Vaccine Strain LaSota.

Authors:  Jiaqi Mu; Xinxin Liu; Xibing Yu; Junjiao Li; Yidong Fei; Zhuang Ding; Renfu Yin
Journal:  Pathogens       Date:  2019-08-09

5.  TMT-based quantitative proteomics analysis reveals the attenuated replication mechanism of Newcastle disease virus caused by nuclear localization signal mutation in viral matrix protein.

Authors:  Zhiqiang Duan; Chao Yuan; Yifan Han; Lei Zhou; Jiafu Zhao; Yong Ruan; Jiaqi Chen; Mengmeng Ni; Xinqin Ji
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

6.  Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt.

Authors:  Ibrahim Moharam; Olayinka Asala; Sven Reiche; Hafez Hafez; Martin Beer; Timm Harder; Christian Grund
Journal:  Virol J       Date:  2021-04-26       Impact factor: 4.099

7.  Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes.

Authors:  J Fréderique de Graaf; Stefan van Nieuwkoop; Theo Bestebroer; Daphne Groeneveld; Casper H J van Eijck; Ron A M Fouchier; Bernadette G van den Hoogen
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

Review 8.  Evolutionary history of cotranscriptional editing in the paramyxoviral phosphoprotein gene.

Authors:  Jordan Douglas; Alexei J Drummond; Richard L Kingston
Journal:  Virus Evol       Date:  2021-03-27

9.  Molecular evolution and genetic variations of V and W proteins derived by RNA editing in Avian Paramyxoviruses.

Authors:  Pachineella Lakshmana Rao; Ravi Kumar Gandham; Madhuri Subbiah
Journal:  Sci Rep       Date:  2020-06-12       Impact factor: 4.379

Review 10.  Development of Plant-Based Vaccines for Prevention of Avian Influenza and Newcastle Disease in Poultry.

Authors:  Ika Nurzijah; Ola A Elbohy; Kostya Kanyuka; Janet M Daly; Stephen Dunham
Journal:  Vaccines (Basel)       Date:  2022-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.